Form 4 for HAE HAEMONETICS CORP
Accepted 2022-11-15 00:00:00 ET · period of report 2022-11-11 · accession 0001127602-22-025631 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-15 | 2022-11-11 | HAE | Simon, Christopher | Pres, CEO, Dir | G - Gift | $0.00 | -8,600 | 205.1K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-11 | G | D | 8,600 | $0.00 | 205,124 | D | — | — | (F2) This number includes unvested restricted stock units previously reported. |